⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

U.S. agrees to sell $39 million of anti-tank weapons to Ukraine: source

Published 10/01/2019, 04:15 PM
U.S. agrees to sell $39 million of anti-tank weapons to Ukraine: source
LMT
-
RTN
-

WASHINGTON (Reuters) - Ukraine has agreed to buy 150 Javelin anti-tank missiles, in a deal worth $39 million, a U.S. congressional aide said on Tuesday, referring to a purchase that is separate from U.S. aid at the center of an impeachment inquiry into President Donald Trump.

This sale, funded with Ukrainian government and not U.S. funds, was finalized in late June or early July, weeks before Trump's July 25 call with Ukrainian President Volodymyr Zelenskiy that was flagged in a whistleblower complaint.

Leaders of congressional committees signed off on the Javelin sale within the past week under an informal review process for major international military sales.

The aide said he expected the sale would be made public shortly. A State Department spokesman did not immediately respond to a request for comment.

Javelin anti-tank missiles are made by Raytheon (NYSE:RTN) Co and Lockheed Martin Corp (NYSE:LMT).

The Javelin sale was first reported by Bloomberg.

The purchase is separate from $391 million in U.S. military assistance for Ukraine that has played major role in the U.S. House of Representatives impeachment inquiry into Trump's.

Ukraine is mired in a conflict with pro-Russian separatists in the east of the country.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.